FDA Approves First Cox-2 Inhibitor for Osteoarthritis Pain

Strategic Insights -

The U.S. Food and Drug Administration (FDA) has approved the first-of-its-kind drug, Celebrex, which is expected to revolutionize the treatment of osteoarthritis pain without the gastrointestinal side effects of traditional painkillers. Developed by Searle, a pharmaceutical division of Monsanto Co., Celebrex is a Cox-2 inhibitor that works by blocking the production of the cyclo-oxygenase-2 enzyme, thereby reducing painful swelling associated with osteoarthritis. Despite concerns about potential side effects, the FDA has cleared the drug for market, with an initial estimated annual sales of $5 billion and projected growth to $25 billion by 2007.

Key Takeaways:

  • The FDA has approved the first Cox-2 inhibitor, Celebrex, for the treatment of osteoarthritis pain.
  • Celebrex, developed by Searle, is a type of drug that blocks the production of cyclo-oxygenase-2 (Cox-2) enzyme.
  • The drug is expected to revolutionize the treatment of osteoarthritis pain without the gastrointestinal side effects of traditional painkillers.
  • Celebrex will be jointly marketed by Searle and Pfizer Inc.
  • The FDA is requiring a warning label for doctors and patients about the risks of ulcers and bleeding in the stomach.
  • Searle's Vice President, G. Steven Geis, claims that the company has achieved its clinical goals with the development of Celebrex.
  • The company's goal with Celebrex is to provide a pain-relieving treatment for arthritis and pain without the gastrointestinal side effects of current treatments.
  • Celebrex is expected to account for $5 billion in annual sales initially, with the market growing to $25 billion annually by 2007.

Statistics:

  • Initial estimate of annual sales: $5 billion
  • Projected growth in sales by 2007: $25 billion
  • Estimated market growth: 500% increase by 2007
  • Number of patients requiring osteoarthritis pain treatment: thousands (exact figure not specified)

Sources:

  • UPI. (Dec. 31). FDA OK's arthritis pain killer.
  • COMTEX News (http://www.comtexnews.com)